Matthew Hill, Making The Dream Of Synthetic Biology A Reality, Panel Discussion at BIO2023

Recorded at the BIO2023 International Convention, Julianna LeMieux, Deputy Editor and Chief of Genetic Engineering News moderates this discussion about the impacts and future of DNA synthesis and synthetic biology with industry thought leaders Matthew Hill, Founder and CEO of Elegen, Madoo Varma, VP of Business Development at DNA Script, Elaine Shapland, Sr. Director of Build Technology Development at Ginkgo Bioworks, and Daniel Arlo, CEO of Ansa.